Xyken, LLC — Department of Health and Human Services SBIR Phase I: NIA

Description

Project SummaryAging increases the risk of GI disorders such as CRCinflammatory bowel diseaseand appendicitisNIH statistic shows that an estimatedtomillion Americans are affected by gastrointestinal diseases annually and nearlyof older adults have one or more age related digestive symptom each yearUnfortunatelythe increasing global geriatric population base is expected to further worsen this situation over the coming yearsTraditional endoscopy is limited for the discovery of the GI tract diseasesAs a new diagnosis toolvideo capsule endoscopy has provided the cheapest and best noninvasive and non ionization solution so far to the problems of GI tract imagingThe advantage of capsule endoscopyCEis that it works in a very simple way as CE is performed via a swallowed capsule containing a tiny video cameraHoweverCE has some major drawbacks including limited field of viewprone to miss detection of diseasesand long diagnose viewing timeIn this SBIR effortwe propose to develop an unprecedented CE imaging technologyWhen completedour CE will provide a completelydegree field of viewing capability with zero blind spotThrough immersive virtual reality display technologyclinicians will be able towalk throughthe real GI tract and conduct a full scale disease screening on the GI tract surroundings at any locationWe envision the following major clinic impact and significant for our projectGreatly improving the diagnosis accuracyWith a full spherical view on the GI tract tissue wallthere will be no GI disorder area missedSignificantly increasing the diagnosis efficiencyWith the immersive display technologiesclinicians will be able to quickly locate the troubled area with no abundant video dataBetter mass acceptance and effective disease prevention through the low cost and pain free CE proceduresThe global capsule endoscopy market was valued at USDmillion inand is expected to grow at a CAGR ofto reach USDmillion byAccording to the W H Oglobal population base pertaining to the age groupyears and above is expected to rise fromintoinThis is expected to significantly improve the patient basetherebydriving the growth of the capsule endoscopy market